Live feed
Filing
SC 13G/A
SC 13G/A0000921895-17-001933·BIOTECHNOLOGY VALUE FUND L P
Schedule 13G ownership disclosure
Capstone Therapeutics Corp.
Security class unavailable · CUSIP: 14068E109
Event date: 2017-07-14
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 2.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000921895-17-001933
- Form type
- SC 13G/A
- Filer
- BIOTECHNOLOGY VALUE FUND L P
- CIK
- CIK 918923
- Filed
- Jul 18, 2017
- Reporting period
- Jul 14, 2017
- Description
- Schedule 13G beneficial ownership